A bill to require the Secretary of Health and Human Services to make determinations of the exclusivity periods for which licensed biological products are eligible.

This bill would require the Secretary of Health and Human Services to decide how long certain biological products (which are medical products made from living sources, like vaccines or treatments) get a period of exclusivity, meaning a time when only the original maker can sell them. No official summary is available for this bill.

Your Vote